PCN38 COST-ANALYSIS OF XELOXVS. FOLFOX-4 ± BEVACIZUMAB...

Value in Health 2007 Vol. 10; Iss. 6

PCN38 COST-ANALYSIS OF XELOXVS. FOLFOX-4 ± BEVACIZUMAB (BEV) IN METASTATIC COLORECTAL CANCER (MCRC) IN AN ITALIAN HOSPITAL SETTING

LP Garrison, G Giuliani, P Ducournau, A Cirrincione
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)65196-0
File:
PDF, 75 KB
english, 2007
Conversion to is in progress
Conversion to is failed